BUSINESS Weekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LENSAR Ends Merger Deal Friday, March 20, 2026 AI Briefing – GSK's Lynavoy receives FDA approval – REPROXALAP rejected again by FDA – LENSAR ends merger deal Advertisement Read Original Article → Related Dispatches [US] · Jun 18 Confidence Among Young Britons Slides to Lowest in Two Years [US] · Jun 18 Clarksville Among Tennessee Cities with the Lowest Gas Prices at the Pump [CA] · Jun 18 International Battery Metals Ltd (IBATF) Q4 2026 Earnings Call Highlights: Navigating ...